Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 10mg | $39.99 | $4.00/mg | In stock | Jul 8 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. BPC-157 is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Orbitrex Peptides sell BPC-157?
Yes — Orbitrex Peptides currently lists BPC-157 in 1 variant starting at $39.99 ($4.00/mg).
Is Orbitrex Peptides's BPC-157 third-party tested?
Yes — Disclosed Labs has indexed 14 Certificates of Analysis for Orbitrex Peptides's BPC-157, with the most recent showing 99.9% purity. Orbitrex Peptides holds an overall trust grade of A (92/100) across all 164 COAs on file.
What is Orbitrex Peptides's trust grade for BPC-157?
Orbitrex Peptides has an overall Disclosed Labs trust grade of A (92/100), computed from 164 COAs across all peptides. The most recent BPC-157 COA was issued by ILS Labs.
Where is the cheapest BPC-157?
As of the latest data, Alpha Peptides offers BPC-157 at $1.82/mg — compare with Orbitrex Peptides's listing at $4.00/mg. See the full BPC-157 price comparison.
Is BPC-157 legal to buy?
BPC-157 is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| WOLV20526US | Apr 2026 | 99.6% | Freedom Diagnostics | Endotoxin | Confirmed | View |
| GLOW70426 | Apr 2026 | 99.8% | Freedom Diagnostics | Endotoxin | Confirmed | View |
| WOLV200226 | Mar 2026 | 99.8% | Vanguard Laboratory | Endotoxin, Sterility, Heavy metals | Unverified | View |
| KLOW800426 | Mar 2026 | 99.4% | Freedom Diagnostics | Endotoxin | Unverified | View |
| GLOW70226A | Jan 2026 | 99.7% | Freedom Diagnostics | Endotoxin | Confirmed | View |
| BPC101225 | Dec 2025 | 98.8% | Chromate | Endotoxin, Heavy metals | Confirmed | View |
| BPC10626 | — | 99.6% | Kovera Labs | Endotoxin, Sterility, Heavy metals | Confirmed1 flag | View |
| ZAOB02 | — | 99.3% | Vanguard Laboratory | Endotoxin | Unverified | View |
| K80ab | — | 99.8% | Freedom Diagnostics | — | Confirmed1 flag | View |
| ZAOB01 | — | 99.5% | Freedom Diagnostics | — | Confirmed1 flag | View |
| BPC10226A | — | 99.5% | Freedom Diagnostics | Endotoxin | Confirmed | View |
| BPC10226B | — | 99.4% | Freedom Diagnostics | Endotoxin | Confirmed | View |
| KLOW80426A | — | 99.6% | Freedom Diagnostics | Endotoxin | Confirmed1 flag | View |
Disclosed Labs